Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial

Propranolol as therapy for cerebral cavernous malformations: a cautionary note

(2022) Robert Shenkar et al.   Journal of Translational Medicine

Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations

(2022) Susanna M. Zuurbier et al.   STROKE

The Influence of Select Medications on Prospective Hemorrhage Risk in Patients with Spinal or Cerebral Cavernous Malformations

(2022) Lauren Previch et al.   World Neurosurgery

Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations

(2021) Joppe Oldenburg et al.   STROKE

Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

(2020) Silvia Lanfranconi et al.   Trials

Familial Cerebral Cavernous Malformations

(2019) Atif Zafar et al.   STROKE

Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial

(2019) Marc C Mabray et al.   Translational Stroke Research

Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study

(2019) Santiago Gomez-Paz et al.   World Neurosurgery

Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study

(2018) Johannes Goldberg et al.   JOURNAL OF NEUROSURGERY

Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel

(2017) Amy Akers et al.   NEUROSURGERY

Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults

(2017) Kelly D. Flemming et al.   JAMA Neurology

Safety of Propranolol Therapy for Severe Infantile Hemangioma

(2016) Sorilla Prey et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data

(2016) Margaret A Horne et al.   LANCET NEUROLOGY

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

(2015) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE

Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol

(2014) Juliette Miquel et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants

(2013) C. Léauté-Labrèze et al.   BRITISH JOURNAL OF DERMATOLOGY

Propranolol for Cerebral Cavernous Angiomatosis

(2013) Irene Berti et al.   CLINICAL PEDIATRICS

Sample size calculations for pilot randomized trials: a confidence interval approach

(2012) Kim Cocks et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

(2012) B. A. Drolet et al.   PEDIATRICS

Propranolol, a very promising treatment for ulceration in infantile hemangiomas: A study of 20 cases with matched historical controls

(2011) Denise Josephina Johanna Hermans et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas

(2011) M. Hogeling et al.   PEDIATRICS

Propranolol Treatment for a Giant Infantile Brain Cavernoma

(2010) Maria Moschovi et al.   JOURNAL OF CHILD NEUROLOGY

Hemorrhage From Cavernous Malformations of the Brain

(2008) Rustam Al-Shahi Salman et al.   STROKE